Long-term IV access in paediatrics - why, what, where, who and how

Mathias Johansen1, Volker Classen2, Karl Muchantef3

  • 1Department of Paediatric Anaesthesia, Montreal Children's Hospital, Montreal, Canada.

Insights

This review covers central venous access devices (CVADs) for children, detailing risks, complications like infections and thrombosis, and optimal management strategies. It also presents a specific technique for inserting tunnelled, cuffed catheters.

Area of Science:

  • Pediatric Medicine
  • Vascular Surgery
  • Medical Devices

Background:

  • Long-term central venous access in children carries risks including procedural complications and catheter-related issues.
  • Complications encompass air embolism, pneumothorax, infections, thrombosis, and stenosis, impacting pediatric patient morbidity and mortality.
  • Syndromic children often present unique anesthetic challenges for central venous access device (CVAD) placement.

Purpose of the Study:

  • To provide a historical and clinical overview of central venous access devices (CVADs) in pediatric long-term use.
  • To detail the origin and management of common CVAD complications, including thrombosis, infections, and occlusion.
  • To update clinicians on the indications, methods, and patient selection for pediatric long-term central venous access.

Main Methods:

  • This narrative review synthesizes existing literature on pediatric central venous access.
  • It examines the development, application, and complications of central venous access devices (CVADs).
  • A specific clinical method for retrograde insertion of a tunnelled and cuffed catheter via the left brachiocephalic vein is presented.

Main Results:

  • Central venous access devices (CVADs) are essential but associated with significant procedural and catheter-related risks.
  • Common complications include catheter-related bloodstream infections, thrombosis, and occlusion, requiring careful management.
  • The review highlights the importance of appropriate patient selection and technique for successful pediatric CVAD placement.

Conclusions:

  • Effective management of pediatric central venous access requires understanding historical context, potential complications, and current best practices.
  • The presented technique offers a specific approach for tunnelled and cuffed catheter insertion in pediatric patients.
  • Optimizing central venous access in children necessitates a comprehensive approach to minimize risks and ensure device longevity.

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
499
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
122
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
150
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
131